When the No Surprises Act took effect in 2022, it promised a reprieve for millions of Americans who had been blindsided by astronomical bills after receiving care from out-of-network providers. By banning these sudden charges, the law successfully shifted the financial battle away from the patient and toward a legal tug-of-war between insurance companies and healthcare providers. However, a recent investigation by CBS News suggests that while the bills have disappeared from patients’ mailboxes, the costs are simply migrating elsewhere through a lucrative and volatile arbitration system.
At the heart of the issue is a baseball style arbitration process where insurers and doctors each submit a final price for a service, and an arbitrator must pick one without any room for negotiation. This setup has birthed a booming industry of resolution specialists and middlemen who help providers secure payouts far exceeding typical market rates. Data reveals staggering discrepancies; some routine lab tests normally costing thirty dollars are being settled for hundreds, while certain surgeons have received awards hundreds of times higher than standard benchmarks. While representatives for these physicians argue that insurance companies intentionally lowball their offers, critics say the current trend is unsustainable.
The financial fallout is likely to hit consumers indirectly via their workplaces. Because roughly seventy percent of these inflated awards are paid out of employer sponsored health plans, businesses cannot absorb these costs indefinitely. Experts warn that employees will eventually feel the pinch through spiked monthly premiums or slashed benefit packages during open enrollment periods. The scale of the problem is immense, with over one million new disputes filed in early 2025 alone, dwarfing original government projections by several orders of magnitude.
Even Representative Frank Pallone, a primary architect of the law, admitted that the results have been disheartening. He pointed specifically to the role of private equity firms that have bought up specialty practices and now aggressively drive these arbitration cases to maximize profit. While Pallone maintains that an arbitration system was a necessary evil to eliminate direct surprise billing for patients, he acknowledged that he never anticipated the process would become this distorted. As arbitrators collect billions in fees and payouts soar, the promise of affordable healthcare remains clouded by this hidden secondary market.
